Market Cap 231.02M
Revenue (ttm) 0.00
Net Income (ttm) -63.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.43
Volume 1,238,200
Avg Vol 387,808
Day's Range N/A - N/A
Shares Out 48.53M
Stochastic %K 28%
Beta 1.79
Analysts Strong Sell
Price Target $16.75

Latest News on ABEO

US FDA declines to approve Abeona's skin disorder treatment

Apr 22, 2024, 4:31 PM EDT - 1 year ago

US FDA declines to approve Abeona's skin disorder treatment


Abeona Therapeutics Provides Regulatory Update on Pz-cel

Apr 22, 2024, 4:05 PM EDT - 1 year ago

Abeona Therapeutics Provides Regulatory Update on Pz-cel


Abeona Therapeutics Announces $50 Million Credit Facility

Jan 8, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Announces $50 Million Credit Facility


Abeona Therapeutics Joins Rare Disease Company Coalition

Jul 19, 2023, 8:30 AM EDT - 1 year ago

Abeona Therapeutics Joins Rare Disease Company Coalition